Anthony Radford
Director/Board Member at GENETIC SIGNATURES LIMITED
Net worth: 119 145 $ as of 2024-05-30
Anthony Radford active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GENETIC SIGNATURES LIMITED | Director/Board Member | 2015-09-14 | - |
Career history of Anthony Radford
Former positions of Anthony Radford
| Companies | Position | Start | End |
|---|---|---|---|
Cellestis Pty Ltd.
 Cellestis Pty Ltd. BiotechnologyHealth Technology Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia. | Director/Board Member | 2011-01-06 | 2012-09-30 |
| Chief Executive Officer | 2009-07-27 | 2012-09-30 | |
| Founder | 2000-11-30 | 2012-09-30 | |
| Amrad Operations Pty Ltd. | Corporate Officer/Principal | 1992-12-31 | 2000-11-30 |
Commonwealth Scientific & Industrial Research Organisation
 Commonwealth Scientific & Industrial Research Organisation Miscellaneous Commercial ServicesCommercial Services Commonwealth Scientific & Industrial Research Organisation provides scientific and industrial research services. It plays a role in collaboration within the Australian national innovation system and as an advisor to government, industry and the community. The company was founded in 1916 and is headquartered in Canberra, Australia. | Corporate Officer/Principal | 1985-09-30 | 1992-11-30 |
Training of Anthony Radford
| LaTrobe University | Doctorate Degree |
Statistics
International
| Australia | 6 |
Operational
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
Sectoral
| Commercial Services | 3 |
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| GENETIC SIGNATURES LIMITED | Commercial Services |
| Private companies | 3 |
|---|---|
Cellestis Pty Ltd.
Cellestis Pty Ltd. BiotechnologyHealth Technology Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia. | Health Technology |
Commonwealth Scientific & Industrial Research Organisation
Commonwealth Scientific & Industrial Research Organisation Miscellaneous Commercial ServicesCommercial Services Commonwealth Scientific & Industrial Research Organisation provides scientific and industrial research services. It plays a role in collaboration within the Australian national innovation system and as an advisor to government, industry and the community. The company was founded in 1916 and is headquartered in Canberra, Australia. | Commercial Services |
| Amrad Operations Pty Ltd. |
- Stock Market
- Insiders
- Anthony Radford
- Experience
